These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 14652277

  • 1. Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years.
    Daling JR, Malone KE, Doody DR, Voigt LF, Bernstein L, Marchbanks PA, Coates RJ, Norman SA, Weiss LK, Ursin G, Burkman RT, Deapen D, Folger SG, McDonald JA, Simon MS, Strom BL, Spirtas R.
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1175-81. PubMed ID: 14652277
    [Abstract] [Full Text] [Related]

  • 2. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.
    Chen WY, Hankinson SE, Schnitt SJ, Rosner BA, Holmes MD, Colditz GA.
    Cancer; 2004 Oct 01; 101(7):1490-500. PubMed ID: 15378477
    [Abstract] [Full Text] [Related]

  • 3. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
    Rosenberg LU, Einarsdóttir K, Friman EI, Wedrén S, Dickman PW, Hall P, Magnusson C.
    Cancer Epidemiol Biomarkers Prev; 2006 Dec 01; 15(12):2482-8. PubMed ID: 17164374
    [Abstract] [Full Text] [Related]

  • 4. Type and duration of exogenous hormone use affects breast cancer histology.
    Kumar AS, Cureton E, Shim V, Sakata T, Moore DH, Benz CC, Esserman LJ, Hwang ES.
    Ann Surg Oncol; 2007 Feb 01; 14(2):695-703. PubMed ID: 17103262
    [Abstract] [Full Text] [Related]

  • 5. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.
    Gammon MD, Hibshoosh H, Terry MB, Bose S, Schoenberg JB, Brinton LA, Bernstein JL, Thompson WD.
    Cancer Epidemiol Biomarkers Prev; 1999 May 01; 8(5):413-9. PubMed ID: 10350436
    [Abstract] [Full Text] [Related]

  • 6. Risk of breast cancer in post-menopausal women using hormone replacement therapy.
    Ratanawichitrasin A, Reansuwan W, Ratanawichitrasin S, Bhodhisuwan K, Kongpatanakul S.
    J Med Assoc Thai; 2002 May 01; 85(5):583-9. PubMed ID: 12188389
    [Abstract] [Full Text] [Related]

  • 7. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
    Shantakumar S, Terry MB, Paykin A, Teitelbaum SL, Britton JA, Moorman PG, Kritchevsky SB, Neugut AI, Gammon MD.
    Am J Epidemiol; 2007 May 15; 165(10):1187-98. PubMed ID: 17337757
    [Abstract] [Full Text] [Related]

  • 8. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
    Olsson HL, Ingvar C, Bladström A.
    Cancer; 2003 Mar 15; 97(6):1387-92. PubMed ID: 12627501
    [Abstract] [Full Text] [Related]

  • 9. Statins and breast cancer in postmenopausal women without hormone therapy.
    Eaton M, Eklof J, Beal JR, Sahmoun AE.
    Anticancer Res; 2009 Dec 15; 29(12):5143-8. PubMed ID: 20044629
    [Abstract] [Full Text] [Related]

  • 10. The relation of reproductive factors to mortality from breast cancer.
    Daling JR, Malone KE, Doody DR, Anderson BO, Porter PL.
    Cancer Epidemiol Biomarkers Prev; 2002 Mar 15; 11(3):235-41. PubMed ID: 11895871
    [Abstract] [Full Text] [Related]

  • 11. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec 15; 15(6):453-65. PubMed ID: 11826770
    [Abstract] [Full Text] [Related]

  • 12. A case-control study of hormone replacement therapy after primary surgical breast cancer treatment.
    Ursic-Vrscaj M, Bebar S.
    Eur J Surg Oncol; 1999 Apr 15; 25(2):146-51. PubMed ID: 10218456
    [Abstract] [Full Text] [Related]

  • 13. Hormone replacement therapy and mammographic screening outcomes in Western Australia.
    Crouchley K, Wylie E, Khong E.
    J Med Screen; 2006 Apr 15; 13(2):93-7. PubMed ID: 16792833
    [Abstract] [Full Text] [Related]

  • 14. An analysis of the effect of selection bias on the association of hormone replacement therapy and breast cancer risk.
    Csizmadi I, Friedenreich CM, Bryant HE, Courneya KS.
    Chronic Dis Can; 2005 Apr 15; 26(2-3):73-9. PubMed ID: 16251013
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer.
    Slattery ML, Potter JD, Curtin K, Edwards S, Ma KN, Anderson K, Schaffer D, Samowitz WS.
    Cancer Res; 2001 Jan 01; 61(1):126-30. PubMed ID: 11196149
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E, Zyriax BC, Eidenmüller B, Boeing H.
    Maturitas; 2007 Jul 20; 57(3):239-46. PubMed ID: 17292571
    [Abstract] [Full Text] [Related]

  • 20. Urinary hydroxyestrogens and breast cancer risk among postmenopausal women: a prospective study.
    Wellejus A, Olsen A, Tjonneland A, Thomsen BL, Overvad K, Loft S.
    Cancer Epidemiol Biomarkers Prev; 2005 Sep 20; 14(9):2137-42. PubMed ID: 16172222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.